课题基金 / 基金详情

Astrocytic Calcineurin and Connexin43 Gap Junctions in Alzheimer's Disease

Astrocytic Calcineurin and Connexin43 Gap Junctions in Alzheimer's Disease
阿尔茨海默病中的星形细胞钙调神经磷酸酶和 Connexin43 间隙连接
批准号:
8718271
负责人:
Melanie Pleiss
金额:
$2.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-02-01 至 2018-01-31

项目摘要

项目成果

Melanie Pleiss的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):作为影响超过520万人的第六大死亡原因,阿尔茨海默病(AD)正在成为一场健康危机。令人失望的是,之前的临床试验显示,在寻找这种毁灭性疾病的治疗方法方面收效甚微。因此,探索新的和可替代的分子靶点是至关重要的。该项目将测试钙调神经磷酸酶(CN)和连接蛋白43 (Cx43)相互作用在阿尔茨海默病进展过程中破坏星形胶质细胞中的间隙连接(GJ)偶联,导致神经功能的有害变化的总体假设。该项目将采用多学科方法,利用一系列AD模型系统,包括人类海马标本、APP/PS1转基因小鼠和大鼠原代星形胶质细胞培养,来研究这一假设。除了优秀的模型系统外,该项目还将使用各种尖端技术,包括荧光共振能量转移(FRET),腺相关病毒(AAV)介导的基因传递和切片电生理学。总体假设将通过以下三个独立的具体目标进行检验:使用FRET和共免疫沉淀(Co-IPs)等技术测试CN在AD进展过程中与Cx43相互作用的假设;利用染料偶联和Western blot等技术,验证β -淀粉样蛋白(a - β)以cn依赖的方式破坏间隙连接(GJ)偶联的假设;利用主动回避范式等认知测量方法以及染料耦合、Western blot和切片电生理学等技术,验证CN/Cx43相互作用破坏AD小鼠模型GJ偶联和神经功能的假设。该项目不仅为神经科学研究提供了卓越的培训,而且将为阿尔茨海默病潜在的新治疗靶点提供极有价值的信息。
英文摘要
DESCRIPTION (provided by applicant): As the sixth leading cause of death that affects over 5.2 million people, Alzheimer's disease (AD) is becoming a health crisis. To much disappointment, previous clinical trials have shown little success in finding a treatment for this devastating disease. Thus, it is critical that new and alternative molecular targets be explored. The proposed project will test the overarching hypothesis that calcineurin (CN) and connexin43 (Cx43) interactions disrupt gap junction (GJ) coupling in astrocytes during the progression of AD leading to detrimental changes in neurologic function. This project will use a multi-disciplinary approach to investigate the hypothesis using an array of AD model systems, including human hippocampal specimens, APP/PS1 transgenic mice, and rat primary astrocyte cultures. In addition to the excellent model systems, this project will use a variety of cutting-edge techniques, including fluorescence resonance energy transfer (FRET), adeno-associated virus (AAV) - mediated gene delivery, and slice electrophysiology. The overarching hypothesis will be examined through three independent specific aims which are as follows: to test the hypothesis that CN interacts with Cx43 during the progression of AD using techniques such as FRET and co-immunoprecipitations (Co-IPs); to test the hypothesis that beta amyloid (A-beta) disrupts gap junction (GJ) coupling in a CN-dependent manner using techniques such as dye coupling and Western blot; to test the hypothesis that CN/Cx43 interactions disrupt GJ coupling and neurologic function in a mouse model of AD using cognitive measures such as the active avoidance paradigm and techniques such as dye coupling, Western blot, and slice electrophysiology. This project not only provides superior training in neuroscience research, but also will provide extremely valuable information into a potential new therapeutic target for AD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Astrocytic Calcineurin and Connexin43 Gap Junctions in Alzheimer's Disease
  • 批准号:
    8932575
  • 项目类别:
  • 资助金额:
    $2.89万
  • 财政年份:
    2015
  • 负责人:
    Melanie Pleiss
  • 依托单位:
海外基金